German Merck to build biodevelopment centres in US and China
Merck has announced plans for process and cell line development centres in the US and China citing biopharmaceutical industry demand for integrated services.
Archives for January 10, 2017
Kite inks Chinese JV and Japanese partnership for lead T Cell candidate
Kite Pharma has formed a joint venture with Shanghai Fosun Pharmaceutical Industrial Development Company to develop and manufacture its cell therapy axicabtagene ciloleucel in the Chinese market.
Strategic partnership forms single-source solution for biopharma
CSSi LifeSciences and BioMARC have announced a strategic partnership to provide 'fully cohesive product development and support' for vaccine and biologic development.
Valeant selling Provenge maker Dendreon to Chinese conglomerate for $820m
Sanpower Group says Dendreon's in-house manufacturing set-up will remain in place as it looks to increase US and Asian penetration of the prostate cancer cell therapy.